Bonannione A 产品活性：Bonannione A (6-Geranylnaringenin; Mimulone) 是一种异戊二烯类黄酮，一种口服有效的蛋白酪氨酸磷酸酶 1B (PTP1B) 抑制剂，IC50 为 14 µM。Bonannione A 触发半胱天冬酶依赖性细胞凋亡。Bonannione A 通过 p53 介导的 AMPK/mTOR 通路诱导自噬。Bonannione A 显示出抗炎、抗自由基和抗癌活性。 产品来源： https://www.medchemexpress.cn/bonannione-a.html 研究领域：Metabolic Enzyme/Protease | Apoptosis | Autophagy 作用靶点：Phosphatase | Apoptosis | Autophagy 来源：植物 | 玄参科 | 毛泡桐 In Vitro: Bonannione A (0-80 µM; 12, 24 hours) significantly inhibits cell proliferation in a dose- and time-dependent way in cancer cell lines. Bonannione A (0-60 µM; 24 hours) triggers caspase-dependent apoptosis in A549 cells. Bonannione A increases accumulation of cells at the apoptotic sub-G1 phase and the number of cells at G2/M phase. Bonannione A (60 µM, 24 h) triggers autophagy without impairment of autophagic flux in A549 cells. Bonannione A remarkably reduced p53 levels. Bonannione A (60 µM, 0-24 h) remarkably decreased the levels of p53 and phospho-mTOR. In Vivo: Bonannione A (25 mg/kg; gavage; 48 and 24 h prior to DSS and every 24 h on the following days; for 5days) ameliorates the symptoms of colitis and delayed their onset. 相关产品：MG-132 | Doxorubicin hydrochloride | Bafilomycin A1 | Tamoxifen | Y-27632 | LY294002 | Paclitaxel | Z-VAD-FMK | Acetylcysteine | Angiotensin II human | 2-Deoxy-D-glucose | Staurosporine | Actinomycin D | SB-431542 | 5-Fluorouracil | Bortezomib | Deferoxamine mesylate | Oxaliplatin | Trametinib | Sorafenib | Temozolomide | Gemcitabine | Decitabine | Mdivi-1 | Rotenone | Etoposide | Elesclomol | Ruxolitinib | Monomethyl auristatin E | Cyclosporin A 品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；设有专业的实验中心和严格的质控、验证体系；提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；产品的生物活性多经各国客户实验验证；Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；与世界各大制药公司及知名科研机构建立了长期的合作。